VC Roundup: More Funds Raise Cash For Biotech; Morphic Closes $51.5m Series A

Five venture capital firms raised new funds to finance biopharma companies in June and five therapeutics developers closed early-stage funding rounds during the last week of June.

DNA

June saw five venture capital firms close new funds to back health care and life science companies, and Kleiner Perkins Caufield & Byers (KPCB) – one of the most prolific VC firms so far this year – disclosed in a June 29 US Securities and Exchange Commission (SEC) filing that it is raising at least $400m for its 17th fund.

Five of the top 10 most active venture capital investors in the US during the first half of 2016 are...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip